Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer

PURPOSE: Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor–positive, lymph node–negative breast cancer. We hypothesized that the clinical value of these new tools would be more fully realized when appropriately integrated with high-qual...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Kim, Hyun-seok, Umbricht, Christopher B., Illei, Peter B., Cimino-Mathews, Ashley, Cho, Soonweng, Chowdhury, Nivedita, Figueroa-Magalhaes, Maria Cristina, Pesce, Catherine, Jeter, Stacie C., Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Turner, Bradley M., Hicks, David G., Jensen, Tyler A., Miller, Dylan V., Armstrong, Deborah K., Connolly, Roisin M., Fetting, John H., Miller, Robert S., Park, Ben Ho, Stearns, Vered, Visvanathan, Kala, Wolff, Antonio C., Cope, Leslie
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455310/
https://ncbi.nlm.nih.gov/pubmed/27998227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.7195
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares